Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Human Biome is a clinical-stage biotechnology company based in Poland that specializes in the development of microbiota-based therapies. The company focuses on the isolation and formulation of specific bacterial strains and full-spectrum microbiota transplants to treat a variety of conditions linked to intestinal dysbiosis. Their lead programs target recurrent Clostridioides difficile infections and inflammatory bowel diseases, utilizing a proprietary platform for the standardization of live biotherapeutic products. Human Biome operates one of the most advanced microbiota processing facilities in Europe, aiming to transition from traditional fecal microbiota transplantation to highly defined, encapsulated microbial consortia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Human Biome.